Details of the Drug Reposition

General Information of This Drug (ID: DMLMN2F)

• Drug Name: CM-AT (DMLMN2F)

Information on Drug Reposition of This Drug

2 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Autism spectrum disorder	DISXK8NV	6A02	Phase 3	[1]
Attention deficit hyperactivity disorder	DISL8MX9	6A05.Z	Phase 3	[1]

References

• [1] ClinicalTrials.gov (NCT00881452) A Trial of CM-AT in Children With Autism. U.S. National Institutes of Health.